Biotech News
-
Valeo Pharma to Report First Quarter 2021 Results and Hold Investors Conference Call / Webcast
March 26, 2021 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”),…
-
Perimeter Medical Imaging AI to Present at Lytham Partners Spring 2021 Investor Conference
March 24, 2021 (Source) — Company Presentation at 2:45 p.m. ET on Tuesday, March 30, 2021 Perimeter Medical…
-
Hemostemix Announces Clinical Trial Update and Contract with GlobeX Data to Encrypt its Communications with Regulatory Authorities
March 18, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) is pleased to…
-
XPhyto announces European Approval for 25 Minute COVID-19 PCR Test
March 18, 2021 (Source) — CE Mark received for in vitro diagnostic (IVD) test for the detection of…
-
Rritual Announces Successful Completion of Second Full Scale Manufacturing Run and Commencement of Third Full Scale Manufacturing Run in Early April
March 17, 2021 (Source) — Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE: RSF) (CSE: RSF.WT) is pleased to provide an update on…
-
Sixth Wave Appoints Puar to Board
March 15, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave”, or the “Company”) is pleased…
-
Sixth Wave Announces Non-Brokered Private Placement of Units
March 12, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave” or the “Company”) is…
-
Perimeter Medical Imaging AI Announces Completion of Warrant Acceleration
March 10, 2021 (Source) — Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical…
-
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test
March 10, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company”), and its…
-
DIAGNOS, following a successful Proof-of-Concept (POC) pilot study, is finalising its new application CARA-STROKE to address Stroke prevention and management, a market estimated at $36 Billion
March 9, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader…
